Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy

Journal of the American College of Cardiology

Volumn 61, Issue 11, 2013, Pages 1169-1176

  Karamitsos, Theodoros D ^a   Dass, Sairia ^a   Suttie, Joseph ^a   Sever, Emily ^a   Birks, Jacqueline ^b   Holloway, Cameron J ^a   Robson, Matthew D ^a   Jerosch Herold, Michael ^c   Watkins, Hugh ^d   Neubauer, Stefan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d NONE

Author keywords

Athletes; Cardiac magnetic resonance imaging; Hypertrophy; Ischemia; Perfusion

Indexed keywords

ADENOSINE; DIAGNOSTIC AGENT; VASODILATOR AGENT;

ADULT; ARTICLE; ATHLETE; BLOOD OXYGEN TENSION; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MAGNETIC RESONANCE; CHEMICAL STRESS; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEOXYGENATION; FEMALE; GENE MUTATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE FIBROSIS; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; MALE; PRIORITY JOURNAL; RISK FACTOR; TISSUE OXYGENATION; CORONARY ARTERY BLOOD FLOW; HEART MUSCLE; METABOLISM; MIDDLE AGED; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY;

ADENOSINE; ADULT; CARDIOMYOPATHY, HYPERTROPHIC; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; OXYGEN CONSUMPTION; VASODILATOR AGENTS;

MLCS; MLOWN;

EID: 84877102843     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.12.024     Document Type: Article

References (27)

1. Watkins H, Ashrafian H, Redwood C. Inherited cardiomyopathies. N Engl J Med 2011;364:1643-56.
2. Camici P, Chiriatti G, Lorenzoni R, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: a study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991;17:879-86.
3. Cecchi F, Olivotto I, Gistri R, et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003;349:1027-35.
4. Petersen SE, Jerosch-Herold M, Hudsmith LE, et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007;115:2418 -25.
5. Maron MS, Olivotto I, Maron BJ, et al. The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54:866 -75.
6. Karamitsos TD, Leccisotti L, Arnold JR, et al. Relationship between regional myocardial oxygenation and perfusion in patients with coronary artery disease: insights from cardiovascular magnetic resonance and positron emission tomography. Circ Cardiovasc Imaging 2010;3: 32-40.
7. Jahnke C, Gebker R, Manka R, et al. Navigator-gated 3D blood oxygen level-dependent CMR at 3.0-T for detection of stress-induced myocardial ischemic reactions. J Am Coll Cardiol Img 2010;3:375- 84.
8. Vohringer M, Flewitt JA, Green JD, et al. Oxygenation-sensitive CMR for assessing vasodilator-induced changes of myocardial oxygenation. J Cardiovasc Magn Reson 2010;12:20.
9. Karamitsos TD, Arnold JR, Pegg TJ, et al. Patients with syndrome X have normal transmural myocardial perfusion and oxygenation: a 3-T cardiovascular magnetic resonance imaging study. Circ Cardiovasc Imaging 2012;5:194 -200.
10. Arnold JR, Karamitsos TD, Bhamra-Ariza P, et al. Myocardial oxygenation in coronary artery disease: insights from blood oxygen level-dependent magnetic resonance imaging at 3 tesla. J Am Coll Cardiol 2012;59:1954-64.
11. Weinsaft JW, Spincemaille P. BOLD new directions in myocardial ischemia imaging-myocardial oxygenation assessment by cardiac magnetic resonance. J Am Coll Cardiol 2012;59:1965-7.
12. Fallavollita JA, Malm BJ, Canty JM Jr. Hibernating myocardium retains metabolic and contractile reserve despite regional reductions in flow, function, and oxygen consumption at rest. Circ Res 2003; 92:48 -55.
13. Ashrafian H, Redwood C, Blair E, Watkins H. Hypertrophic cardiomyopathy: a paradigm for myocardial energy depletion. Trends Genet 2003;19:263- 8.
14. Crilley JG, Boehm EA, Blair E, et al. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol 2003;41:1776-82.
15. Cheng AS, Robson MD, Neubauer S, Selvanayagam JB. Irreversible myocardial injury: assessment with cardiovascular delayed-enhancement MR imaging and comparison of 1.5 and 3.0 T-initial experience. Radiology 2007;242:735-42.
16. Karamitsos TD, Hudsmith LE, Selvanayagam JB, Neubauer S, Francis JM. Operator induced variability in left ventricular measurements with cardiovascular magnetic resonance is improved after training. J Cardiovasc Magn Reson 2007;9:777- 83.
17. Cerqueira MD, Weissman NJ, Dilsizian V, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539-42.
18. Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation 2003;108:432-7.
19. Russel IK, Brouwer WP, Germans T, et al. Increased left ventricular torsion in hypertrophic cardiomyopathy mutation carriers with normal wall thickness. J Cardiovasc Magn Reson 2011;13:3.
20. Gandjbakhch E, Gackowski A, Tezenas du Montcel S, et al. Early identification of mutation carriers in familial hypertrophic cardiomyopathy by combined echocardiography and tissue Doppler imaging. Eur Heart J 2010;31:1599-607.
21. Germans T, Russel IK, Gotte MJ, et al. How do hypertrophic cardiomyopathy mutations affect myocardial function in carriers with normal wall thickness? Assessment with cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;12:13.
22. Hildick-Smith DJ, Johnson PJ, Wisbey CR, Winter EM, Shapiro LM. Coronary flow reserve is supranormal in endurance athletes: an adenosine transthoracic echocardiographic study. Heart 2000;84: 383-9.
23. Kjaer A, Meyer C, Wachtell K, et al. Positron emission tomographic evaluation of regulation of myocardial perfusion in physiological (elite athletes) and pathological (systemic hypertension) left ventricular hypertrophy. Am J Cardiol 2005;96:1692- 8.
24. Kalliokoski KK, Nuutila P, Laine H, et al. Myocardial perfusion and perfusion reserve in endurance-trained men. Med Sci Sports Exerc 2002;34:948 -53.
25. Ingwall JS. ATP and the Heart. Norwell, MA: Kluwer Academic, 2002.
26. Czernin J, Muller P, Chan S, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993;88: 62-9.
27. Uren NG, Camici PG, Melin JA, et al. Effect of aging on myocardial perfusion reserve. J Nucl Med 1995;36:2032- 6.